Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 11/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7678491 | 0.95 | TYMS (0.41) | TYMSKDRNPC1MAPTRAB9A | |
| SCHEMBL7676666 | 0.88 | KDR (0.40) | TYMSKDRMAPTEGFRERBB2 | |
| SCHEMBL7679412 | 0.87 | KDR (0.40) | TYMSKDRMAPTEGFRERBB2 | |
| SCHEMBL7672881 | 0.86 | NPC1 (0.35) | KDRNPC1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL7676537 | 0.86 | KDR (0.41) | TYMSKDRMAPTEGFRERBB2 | |
| SCHEMBL7670929 | 0.83 | TYMS (0.43) | TYMSKDREGFRERBB2ALDH1A1 | |
| SCHEMBL7889221 | 0.81 | KDR (0.39) | TYMSKDRMAPTEGFRERBB2 | |
| SCHEMBL6862014 | 0.80 | TYMS (0.40) | TYMSEGFRERBB2ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL7672774 | 0.79 | LMNA (0.48) | TYMSSMN1; SMN2ALDH1A1LMNATHRB | |
| Hydrochloric Acid SCHEMBL7672979 | 0.79 | TYMS (0.45) | TYMSSMN1; SMN2ALDH1A1LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6479514-B1 | FOR THE CONTROL OF HELICOBACTER BACTERIA IN INFECTED PATIENTS | ALTANA PHARMA AG (DE) | 2002-11-12 | — | — | US | disclosed |
| EP-1086094-A1 | QUINOLINE-AMINOMETHYL-PYRIDYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999061438-A1 | QUINOLINE-AMINOMETHYL-PYRIDYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1999-12-02 | — | — | WO | disclosed |